aid: abata-therapeutics
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/abata-therapeutics.png
name: Abata Therapeutics
description: Abata Therapeutics was a biotechnology company developing engineered regulatory T cell (Treg)
  therapies aimed at restoring immune tolerance in tissue-specific autoimmune and inflammatory diseases,
  with lead programs directed at progressive multiple sclerosis and type 1 diabetes. Founded in 2021 and
  based in the Boston/Cambridge area (Watertown, Massachusetts), the company was launched by Third Rock
  Ventures and counted Lightspeed Venture Partners among its backers. As a therapeutics developer it
  operated no public developer program, API, or documentation surface. As of this enrichment pass its
  corporate domains (abatatx.com and abatatherapeutics.com) resolve to a WP Engine host but serve an
  unconfigured "Site Not Configured" 404, indicating the public website has been deprovisioned and the
  company appears to have wound down.
url: https://raw.githubusercontent.com/api-evangelist/abata-therapeutics/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- lightspeed-venture-partners
x-tier: stub
x-tier-reason: portfolio-lead
x-industry: biotechnology
x-website-status: offline-404-wpengine-unconfigured
x-website-probed: '2026-07-17'
x-has-api-surface: false
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-17'
tags:
- Company
- Biotechnology
- Therapeutics
- Cell Therapy
- Immunology
- Autoimmune
- Life Sciences
- Healthcare
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence